–
Calidi Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
FY22:
0.03
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−23.1
FY23:
−29.0
FY24:
−21.8
FY25:
−20.2
(positive)
millions USD
FY21:
–
FY22:
−22.9
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.9
FY22:
−25.4
FY23:
−29.2
FY24:
−22.2
FY25:
−20.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.9
FY22:
−25.4
FY23:
−29.2
FY24:
−22.1
FY25:
−19.9
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.